Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dexcom (DXCM) Debt to Equity (2017)

Dexcom has reported Debt to Equity over the past 8 years, most recently at $0.27 for Q1 2017.

  • Quarterly Debt to Equity rose 3571.71% to $0.27 in Q1 2017 from the year-ago period, while the trailing twelve-month figure was $0.27 through Mar 2017, up 3571.71% year-over-year, with the annual reading at $0.01 for FY2015, 68.31% down from the prior year.
  • Debt to Equity was $0.27 for Q1 2017 at Dexcom, up from $0.01 in the prior quarter.
  • Over five years, Debt to Equity peaked at $0.27 in Q1 2017 and troughed at $0.01 in Q1 2016.
  • The 5-year median for Debt to Equity is $0.05 (2014), against an average of $0.07.
  • Year-over-year, Debt to Equity crashed 73.35% in 2016 and then surged 3571.71% in 2017.
  • A 5-year view of Debt to Equity shows it stood at $0.08 in 2013, then plummeted by 59.42% to $0.03 in 2014, then tumbled by 68.31% to $0.01 in 2015, then dropped by 29.28% to $0.01 in 2016, then surged by 3571.71% to $0.27 in 2017.
  • Per Business Quant, the three most recent readings for DXCM's Debt to Equity are $0.27 (Q1 2017), $0.01 (Q1 2016), and $0.01 (Q4 2015).